While most mutations in the genetic code do not significantly alter cellular phenotype, so-called “driver” mutations, such as BRCA1/2, are considered high penetrance mutations that confer women with a substantially higher risk of developing breast and/or ovarian cancer during their lifetime. The gene discussed is BRCA1; the disease is ovarian carcinoma.